Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
Aged
Biopsy
Cholangiopancreatography, Magnetic Resonance
Cholangitis, Sclerosing
/ diagnosis
Diagnosis, Differential
Humans
Immunoglobulin G
/ blood
Immunoglobulin G4-Related Disease
/ diagnosis
Immunologic Factors
/ therapeutic use
Liver
/ diagnostic imaging
Male
Positron-Emission Tomography
Rituximab
/ therapeutic use
Case report
IgG4-related disease
Liver cirrhosis
Rituximab
Secondary cholangitis
Journal
Annals of hepatology
ISSN: 1665-2681
Titre abrégé: Ann Hepatol
Pays: Mexico
ID NLM: 101155885
Informations de publication
Date de publication:
Historique:
received:
16
05
2017
accepted:
06
07
2017
entrez:
23
5
2019
pubmed:
23
5
2019
medline:
14
4
2020
Statut:
ppublish
Résumé
IgG4-related disease is a recently-described fibro-inflammatory condition with characteristic histopathological findings in the organs involved. The most commonly affected organs are pancreas, lymph nodes, and retroperitoneum. Liver disease usually involves bile structures and therefore IgG4-related disease is considered a cause of secondary sclerosing cholangitis. One out of three patients with IgG4 sclerosing cholangitis also presents autoimmune pancreatitis, although it can be associated with manifestations in other organs. One of the main features of IgG4-related disease is its good prognosis due to the great response to glucocorticoid therapy. However, relapse of the disease is not uncommon, especially when steroid therapy is decreased or stopped. Rituximab seems to be an effective treatment to achieve remission of the disease. We report the case of a 74 year-old man diagnosed with IgG4-related disease based on increase of serum IgG4 levels, imaging and histopathological findings, with systemic involvement including sclerosing cholangitis. Despite the absence of liver fibrosis at onset, the early use of glucocorticoids and rituximab therapy, the patient presented clinical and analytical deterioration, leading to secondary biliary cirrhosis. In conclusion, this clinical case highlights the importance of prompt diagnosis and therapeutics for sclerosing cholangitis secondary to IgG4-related disease in order to avoid progression of the disease and development of liver cirrhosis, as well as the refractory, aggressive nature of the disease in some cases as this one.
Identifiants
pubmed: 31113593
pii: S1665-2681(19)30325-4
doi: 10.5604/01.3001.0012.7916
pii:
doi:
Substances chimiques
Immunoglobulin G
0
Immunologic Factors
0
Rituximab
4F4X42SYQ6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-219Informations de copyright
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.